A Novel Anti-Inflammatory Effect for High Density Lipoprotein.

Area of Science:

• Vascular Biology
• Immunology
• Cellular Signaling

Background:

• High density lipoprotein (HDL) possesses anti-inflammatory properties beyond reverse cholesterol transport.
• The acute signaling pathways activated by HDL in endothelial cells remain largely unexplored.
• Chronic HDL anti-inflammatory effects are often linked to cell adhesion molecule modulation.

Purpose of the Study:

• To investigate the acute effects of HDL on endothelial cell signaling.
• To elucidate the role of HDL in regulating leukocyte trafficking initiation.
• To identify the specific HDL components and receptors involved in these processes.

Main Methods:

• Utilized human primary endothelial cell cultures.
• Employed murine apoA-I knockout models.
• Investigated endothelial cell exocytosis and leukocyte recruitment.
• Examined signaling cascades involving protein kinase C (PKC) and scavenger receptor-BI.

Main Results:

• High density lipoprotein (HDL) was found to decrease endothelial cell exocytosis.
• Apolipoprotein A-I (ApoA-I), a major HDL component, mediates this inhibition.
• ApoA-I interacts with endothelial scavenger receptor-BI, activating a protective PKC signaling pathway.
• ApoA-I's action limits leukocyte recruitment by preventing endothelial exocytosis.

Conclusions:

• HDL inhibits endothelial exocytosis, a critical early event in leukocyte trafficking.
• ApoA-I is the primary mediator of HDL's effect on endothelial exocytosis via scavenger receptor-BI and PKC signaling.
• These findings suggest a novel mechanism by which HDL may combat vascular inflammation.